Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Fell Below 20 DMA | Bearish | 1.35% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 1.35% | |
| NR7 | Range Contraction | 1.35% | |
| Down 3 Days in a Row | Weakness | 1.35% | |
| Gapped Down | Weakness | 1.35% | |
| Outside Day | Range Expansion | -0.36% |
| Alert | Time |
|---|---|
| Possible NR7 | about 19 hours ago |
| Possible Inside Day | about 19 hours ago |
| Possible NR7 | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 1% | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 40.0899 |
| 52 Week Low | 23.1558 |
| Average Volume | 6,572 |
| 200-Day Moving Average | 35.41 |
| 50-Day Moving Average | 37.76 |
| 20-Day Moving Average | 38.46 |
| 10-Day Moving Average | 38.65 |
| Average True Range | 0.68 |
| RSI (14) | 50.00 |
| ADX | 12.19 |
| +DI | 21.28 |
| -DI | 22.98 |
| Chandelier Exit (Long, 3 ATRs) | 38.05 |
| Chandelier Exit (Short, 3 ATRs) | 38.45 |
| Upper Bollinger Bands | 40.25 |
| Lower Bollinger Band | 36.67 |
| Percent B (%b) | 0.44 |
| BandWidth | 9.32 |
| MACD Line | 0.22 |
| MACD Signal Line | 0.37 |
| MACD Histogram | -0.1449 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 38.71 | ||||
| Resistance 3 (R3) | 38.66 | 38.46 | 38.64 | ||
| Resistance 2 (R2) | 38.46 | 38.35 | 38.49 | 38.61 | |
| Resistance 1 (R1) | 38.36 | 38.28 | 38.41 | 38.41 | 38.59 |
| Pivot Point | 38.16 | 38.16 | 38.19 | 38.19 | 38.16 |
| Support 1 (S1) | 38.06 | 38.04 | 38.11 | 38.11 | 37.93 |
| Support 2 (S2) | 37.86 | 37.97 | 37.88 | 37.91 | |
| Support 3 (S3) | 37.76 | 37.86 | 37.88 | ||
| Support 4 (S4) | 37.81 |
